Sofosbuvir (Sovaldi) for hepatitis C virus.
Mary Lomberk is a pharmacy resident at Novant Health Winston-Salem, Winston Salem, N.C. Olga M. Klibanov is a professor of pharmacy at Wingate University, Wingate, N.C.
Mary
M
Lomberk
Olga M
OM
Klibanov
D000998:Antiviral Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D017277:Drug Approval; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D000069474:Sofosbuvir; D014481:United States; D014486:United States Food and Drug Administration; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
D000998:Antiviral Agents; D014542:Uridine Monophosphate; D000069474:Sofosbuvir